High efficacy of monomethoxypolyethylene glycolconjugated l-asparaginase (PEG2-ASP) in two patients with hematological malignancies
- 31 December 1991
- journal article
- case report
- Published by Elsevier in Leukemia Research
- Vol. 15 (6) , 525-530
- https://doi.org/10.1016/0145-2126(91)90064-z
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1986
- Immune Responses to Polyethylene Glycol Modified L-Asparaginase in MiceInternational Archives of Allergy and Immunology, 1985
- MODIFICATION OF E. COLI ASPARAGINASE WITH 2,4-BIS(O-METHOXYPOLYETHYLENE GLYCOL)-6-CHLORO-S-TRIAZINE(ACTIVATED PEG2); DISAPPEARANCE OF BINDING ABILITY TOWARDS ANTI-SERUM AND RETENTION OF ENZYMIC ACTIVITYChemistry Letters, 1980
- Modification of E. coli L-asparaginase with polyethylene glycol: Disappearance of binding ability to anti-asparaginase serumBiochemical and Biophysical Research Communications, 1978
- L-Asparaginase: Clinical, Biochemical, Pharmacological, and Immunological StudiesAnnals of Internal Medicine, 1971